Concentrations
 12 Months Ended
Jun. 30, 2012
Concentrations [Abstract]  
Concentrations
8.       Concentrations

At June 30, 2012, we had five distributors that individually accounted for 22%, 13%, 13%, 12% and 10% of accounts receivable. At June 30, 2011, we had one distributor that individually accounted for 14% of accounts receivable.

Revenues from one distributor totaled $6,746,000 or 35%, $7,824,000 or 33% and $9,890,000 or 43% of net revenues during the years ended June 30, 2012, 2011 and 2010, respectively.  For the year ended June 30, 2012, approximately 80% of the distributor's revenue came from one customer. Revenues from another distributor totaled $1,870,000 or 10% and $2,229,000 or 10% of net revenues for the years ended June 30, 2012 and 2011, respectively.

The following is a summary of product revenues as a percentage of total net revenues for the Company's principal product lines:

 
2012
 
 
2011
 
 
2010
 
AXP
 
 
39
%
 
 
34
%
 
 
40
%
BioArchive
 
 
32
%
 
 
37
%
 
 
36
%
Res-Q/MXP
 
 
11
%
 
 
11
%
 
 
5
%
ThermoLine
 
 
4
%
 
 
6
%
 
 
7
%
CryoSeal
 
 
7
%
 
 
3
%
 
 
3
%

We had sales to customers as follows for the years ended June 30:

 
2012
 
 
2011
 
 
2010
 
United States
 
$
10,783,000
 
 
$
13,745,000
 
 
$
13,827,000
 
Asia
 
 
4,010,000
 
 
 
3,697,000
 
 
 
4,303,000
 
Europe
 
 
1,806,000
 
 
 
3,453,000
 
 
 
3,117,000
 
South America
 
 
1,505,000
 
 
 
1,904,000
 
 
 
1,405,000
 
Other
 
 
919,000
 
 
 
601,000
 
 
 
436,000
 
 
$
19,023,000
 
 
$
23,400,000
 
 
$
23,088,000
 

The Company has a contract manufacturer in Costa Rica that produces the AXP and MXP disposable bag sets.  The Company's net equipment is summarized below by geographic area:

 
June 30, 2012
 
 
June 30, 2011
 
United States
 
$
1,269,000
 
 
$
904,000
 
Costa Rica
 
 
205,000
 
 
 
195,000
 
All other countries
 
 
178,000
 
 
 
211,000
 
Total equipment, net
 
$
1,652,000
 
 
$
1,310,000